Chinese Hamster Ovary cell line, CHO-derived human Wnt-2 protein
Human Wnt-2 (Ser26-Thr360) Accession # P09544.1
Human sFRP-1 (Ser32-Lys314) Accession # AAB70793.1
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
<0.10 EU per 1 μg of the protein by the LAL method.
N-terminal sequence Analysis
Ser26 (Wnt-2) & Ser32 (sFRP-1)
Predicted Molecular Mass
38 kDa (Wnt-2) & 33 kDa (sFRP-1)
30-45 kDa, under reducing conditions.
Measured by its ability to activate Wnt induced TCF reporter activity in HEK293 human embryonic kidney cells. The ED50 for this effect is 10.0-150 ng/mL.
Recombinant Human Wnt-2/sFRP-1 Complex Protein, CF Scientific Data Examples
Recombinant Human Wnt‑2/sFRP-1 Complex Bioactivity.
Recombinant Human Wnt-2/sFRP-1 (Catalog # 11117-WN) activates TCF reporter activity in HEK293 human embryonic kidney cells. The ED50 for this effect is 10.0-150 ng/mL.
Formulation, Preparation and Storage
What does CF mean?
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our
Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant
protein to be stored at a more dilute concentration.
The carrier free version does not contain BSA.
What formulation is right for me?
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or
as an ELISA standard.
In contrast, the carrier free protein is recommended for applications, in which the presence of BSA
Lyophilized from a 0.2 μm filtered solution in MOPS and NaCl with Trehalose.
Reconstitute at 100 μg/mL in PBS.
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
3 months, -20 to -70 °C under sterile conditions after reconstitution.
Wnt-2 is one of 19 vertebrate members of the Wingless-type MMTV integration site (Wnt) family of highly conserved cysteine-rich secreted glycoproteins that are important for normal developmental processes (1). Human Wnt-2 is a 35 kDa, secreted, glycosylated member of the Wnt family of developmental proteins. It is considered a class 1 Wnt based on its strong transforming activity on C57MG cells. Human Wnt-2 is synthesized as a 360 amino acid (aa) precursor that contains a 335 aa mature region. The mature region contains 24 cysteines and two potential N-linked glycosylation sites. Mature human Wnt-2 is 96% aa identical to mature mouse and rat Wnt-2. Wnt-2 is produced by mammary myoepithelial cells, endometrial epithelial cells, and breast fibroblasts (2, 3). Wnts bind to the cell surface Frizzled family receptors in conjunction with low-density lipoprotein receptor-related protein family receptors (LRP5 or 6) resulting in the stabilization of intracellular beta -catenin levels (4). As intracellular beta -catenin levels rise, beta -catenin binds to TCF/LEF transcription factors leading to expression of Wnt target genes (5). Wnt-2 is known to bind to sFRPs, a family of secreted molecules that contain an N-terminal cysteine-rich domain (CRD) highly similar to the CRDs of the Frizzled family receptors (6,7). More than one molecule of sFRP is suggested to participate in the interaction with each Wnt molecule (7). R&D Systems produces biologically active human Wnt-2 protein in a complex with human sFRP-1, and this Wnt-2/sFRP-1 complex is stable in the physiological buffer without detergent. Expression of Wnt-1, Wnt-2, E-cadherin, and beta -catenin is a common occurrence in non-small cell lung cancer (NSCLC) and is related to tumor histology and grade (8). Wnt-2 signaling is required for TGF-beta -mediated endothelial-to-mesenchymal transition (EndMT) of human aortic endothelial cells (HAECs), suggesting that Wnt-2 may contribute to atherosclerotic plaque development, and render Wnt-2 as a potential target for therapeutic intervention aiming at controlling atherosclerosis (9).
Willert, K. and R. Nusse (2012) Cold Spring Harb. Perspect. Biol. 4:a007864.
Van Ooyen, A. et al. (1985) EMBO J. 4:2905.
Burrus, L.W. and A.P. McMahon (1995) Exp. Cell Res. 220:363.
MacDonald, B.T. and X. He (2012) Cold Spring Harb. Perspect. Biol. 4:a007880.
Korinek, V. et al. (1997) Science 275:1784.
Dennis, S. et al. (1999) J. Cell Sci. 112:3815.
Bafico, A. et al. (1999) J. Biol. Chem. 274:16180.
Wrona, A. et al. (2021) Histochem. Cytochem. 69:711.
Zhang, J. et al. (2021) Front. Cardiovasc. Med. 8:751720.
Wingless-type MMTV Integration Site Family Member 2
Entrez Gene IDs
7472 (Human); 22413 (Mouse); 114487 (Rat)
INT1L1, INT1L1secreted growth factor, IRP, IRPprotein Wnt-2, Int-1-like protein 1, Int-1-related protein, Wnt-2, Wnt2, wingless-type MMTV integration site family member 2
Citations for Recombinant Human Wnt-2/sFRP-1 Complex Protein, CF
Which Brands are Currently Available on bio‑techne.com? R&D Systems, Tocris Bioscience and ProteinSimple branded products are available to purchase through bio‑techne.com. ProteinSimple branded instruments are available to quote. ACD branded products will be available on bio‑techne.com in the near future. Novus Biologicals branded products are not currently available on bio‑techne.com and can be found at novusbio.com.
Setting the standard in quality research reagents for over 30 years
A trusted leader in quality life science reagents
Your trusted supplier for innovative and high performance life science reagents
Proprietary systems and consumables for simpler, more quantitative and affordable protein analysis
Proprietary RNAscope® technology capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity
A world leader in developing liquid biopsy based diagnostics